Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Inventory Average (2021 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Inventory Average readings, the most recent being $64.0 million for Q1 2026.

  • On a quarterly basis, Inventory Average rose 164.36% to $64.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $64.0 million, a 164.36% increase, with the full-year FY2025 number at $40.6 million, up 41.35% from a year prior.
  • Inventory Average hit $64.0 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from $48.1 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $64.0 million in Q1 2026 to a low of $8.4 million in Q1 2022.
  • Median Inventory Average over the past 5 years was $27.5 million (2024), compared with a mean of $29.2 million.
  • Biggest five-year swings in Inventory Average: skyrocketed 290.26% in 2022 and later decreased 17.07% in 2025.
  • Kiniksa Pharmaceuticals International's Inventory Average stood at $18.1 million in 2022, then soared by 56.56% to $28.4 million in 2023, then fell by 2.93% to $27.5 million in 2024, then surged by 74.93% to $48.1 million in 2025, then skyrocketed by 32.97% to $64.0 million in 2026.
  • The last three reported values for Inventory Average were $64.0 million (Q1 2026), $48.1 million (Q4 2025), and $44.8 million (Q3 2025) per Business Quant data.